Shares of Dr Reddy’s Laboratories jumped nearly 2 per cent on the Bombay Stock Exchange after the company on Friday announced that the US drug regulator has completed the audit of active pharmaceutical ingredients (APIs) manufacturing plant at Srikakulam special economic zone (SEZ) in Andhra Pradesh with no observations.
Following the development, shares of company gained as much as 1.76 per cent to trade at Rs 2688.00 apiece on the Bombay Stock Exchange.
In a similar fashion, stocks of company were trading 1.73 per cent higher at Rs 2,686.60 apiece on the National Stock Exchange.
Meanwhile, the broader benchmark BSE Sensex was trading at 29,407.80, down 48.83 points or 0.17 per cent, at 11:40 hours.